The predictive value of Ki-67 before neoadjuvant chemotherapy for breast cancer: a systematic review and meta-analysis
C Xianyu, H Chao, H Dongdong, Z Meirong… - Future …, 2017 - Taylor & Francis
Aim: To review the predictive values of Ki-67 before neoadjuvant chemotherapy (NAC) for
breast cancer patients. Methods: PubMed and EMBASE were searched. Random-effect …
breast cancer patients. Methods: PubMed and EMBASE were searched. Random-effect …
Ki-67 labeling index is a predictive marker for a pathological complete response to neoadjuvant chemotherapy in breast cancer: a meta-analysis
M Tao, S Chen, X Zhang, Q Zhou - Medicine, 2017 - journals.lww.com
Background: A pathological complete response (pCR) after neoadjuvant chemotherapy
(NCT) is a strong indicator of the benefit of therapy and presents an early surrogate for a …
(NCT) is a strong indicator of the benefit of therapy and presents an early surrogate for a …
OCT4 but not SOX2 expression correlates with worse prognosis in surgical patients with triple-negative breast cancer
JM Zhang, K Wei, M Jiang - Breast Cancer, 2018 - Springer
Background Octamer-binding transcription factor 4 (OCT4) and SRY (sex determining region
Y)-box 2 (SOX2) are common biomarkers of cancer stem cells, which contribute to the …
Y)-box 2 (SOX2) are common biomarkers of cancer stem cells, which contribute to the …
Impact of Topoisomerase IIα, PTEN, ABCC1/MRP1, and KI67 on triple-negative breast cancer patients treated with neoadjuvant chemotherapy
F Guestini, K Ono, M Miyashita, T Ishida… - Breast cancer research …, 2019 - Springer
Purpose Triple-negative breast cancer (TNBC) patients with residual disease following
neoadjuvant chemotherapy (NAC) harbor higher risk of relapse, and eventual demise …
neoadjuvant chemotherapy (NAC) harbor higher risk of relapse, and eventual demise …
[HTML][HTML] Neoadjuvant chemotherapy in triple negative breast cancer: correlation between androgen receptor expression and pathological response
AA Mohammed, FM Elsayed, M Algazar… - Asian Pacific Journal …, 2020 - ncbi.nlm.nih.gov
Background: There is growing evidence that the response to chemotherapy may be affected
by Androgen Receptor (AR) expression suggesting that triple-negative breast cancers …
by Androgen Receptor (AR) expression suggesting that triple-negative breast cancers …
Is the presence of edema and necrosis on T2WI pretreatment breast MRI the key to predict pCR of triple negative breast cancer?
TL Harada, T Uematsu, K Nakashima, T Sugino… - European …, 2020 - Springer
Purpose Given that a pathological complete response (pCR) after neoadjuvant
chemotherapy (NAC) is an important prognostic factor, evaluating pretreatment imaging …
chemotherapy (NAC) is an important prognostic factor, evaluating pretreatment imaging …
Auranofin sensitizes breast cancer cells to paclitaxel chemotherapy by disturbing the cellular redox system
D Natarajan, NR Prasad, M Sudharsan… - Cell Biochemistry …, 2023 - Wiley Online Library
The intrinsic redox status of cancer cells limits the efficacy of chemotherapeutic drugs.
Auranofin, a Food and Drug Administration‐approved gold‐containing compound …
Auranofin, a Food and Drug Administration‐approved gold‐containing compound …
Prediction of treatment response in triple negative breast cancer from whole slide images
The automatic analysis of stained histological sections is becoming increasingly popular.
Deep Learning is today the method of choice for the computational analysis of such data …
Deep Learning is today the method of choice for the computational analysis of such data …
The prognostic value of changes in Ki67 following neoadjuvant chemotherapy in residual triple-negative breast cancer: a Swedish nationwide registry-based study
J Nyqvist-Streng, M Helou, K Helou… - Breast Cancer Research …, 2025 - Springer
Purpose To evaluate the prognostic significance of changes in pre-and post-neoadjuvant
chemotherapy (NACT) Ki67 in patients with primary invasive triple-negative breast cancer …
chemotherapy (NACT) Ki67 in patients with primary invasive triple-negative breast cancer …
Exploring the effectiveness of molecular subtypes, biomarkers, and genetic variations as first-line treatment predictors in Asian breast cancer patients: a systematic …
NWS Bahrin, SNI Matusin, A Mustapa, LZ Huat… - Systematic …, 2024 - Springer
Background Breast cancer incidence has been on the rise significantly in the Asian
population, occurring at an earlier age and a later stage. The potential predictive value of …
population, occurring at an earlier age and a later stage. The potential predictive value of …